Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules

02.05.2024 - BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) - Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; 'Cyclacel' or the 'Company'), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today ... Seite 1

Related Keywords

United States , ,Cyclacel Pharmaceuticals Announces Closing ,Hc Wainwright Co ,Nasdaq ,Cyclacel Pharmaceuticals Inc ,Pharmaceuticals Announces Closing ,Private Placement ,Priced At The Market Under ,Securities Act ,